Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls: Concomitant assessment of perforin, IFN-γ and IL-4 secretion

Journal of Immunological Methods

Volumn 308, Issue 1-2, 2006, Pages 216-230

  Burton, Catherine T ^a   Gotch, Frances ^a   Imami, Nesrina ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Highly active antiretroviral therapy (HAART); Interferon gamma; Interleukin 4; Lymphocyte responses; Perforin; T cell anergy; T cell memory

Indexed keywords

ANTIRETROVIRUS AGENT; CELL ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; VIRUS PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CELL SECRETION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLUENZA VIRUS; PRIORITY JOURNAL; PROTEIN SECRETION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; T LYMPHOCYTE;

ANTIGENS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MEMBRANE GLYCOPROTEINS; MITOGENS; PORE FORMING CYTOTOXIC PROTEINS; RNA, VIRAL; T-LYMPHOCYTE SUBSETS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; ORTHOMYXOVIRIDAE; SIMPLEXVIRUS;

EID: 30844467938     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.11.005     Document Type: Article

References (48)

1. T.M. Allen, D.H. O'Connor, P. Jing, J.L. Dzuris, B.R. Mothe, T.U. Vogel, E. Dunphy, M.E. Liebl, C. Emerson, N. Wilson, K.J. Kunstman, X. Wang, D.B. Allison, A.L. Hughes, R.C. Desrosiers, J.D. Altman, S.M. Wolinsky, A. Sette, and D.I. Watkins Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia Nature 407 6802 2000 386
2. V. Appay, D.F. Nixon, S.M. Donahoe, G.M. Gillespie, T. Dong, A. King, G.S. Ogg, H.M. Spiegel, C. Conlon, C.A. Spina, D.V. Havlir, D.D. Richman, A. Waters, P. Easterbrook, A.J. McMichael, and S.L. Rowland-Jones HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function J. Exp. Med. 192 1 2000 63
3. A. Arno, L. Ruiz, M. Juan, A. Jou, M. Balague, M.K. Zayat, S. Marfil, J. Martinez-Picado, M.A. Martinez, J. Romeu, R. Pujol-Borrell, C. Lane, and B. Clotet Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with
4. B. Autran, G. Carcelaint, T.S. Li, G. Gorochov, C. Blanc, M. Renaud, M. Durali, D. Mathez, V. Calvez, J. Leibowitch, C. Katlama, and P. Debre Restoration of the immune system with anti-retroviral therapy Immunol. Lett. 66 1-3 1999 207
5. M.R. Betts, J.M. Brenchley, D.A. Price, S.C. De Rosa, D.C. Douek, M. Roederer, and R.A. Koup Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation J. Immunol. Methods 281 1-2 2003 65
6. K.T. Brunner, J. Mauel, J.C. Cerottini, and B. Chapuis Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs Immunology 14 2 1968 181
7. P. Champagne, G.S. Ogg, A.S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G.P. Rizzardi, S. Fleury, M. Lipp, R. Forster, S. Rowland-Jones, R.P. Sekaly, A.J. McMichael, and G. Pantaleo Skewed maturation of memory HIV-specific CD8 T lymphocytes Nature 410 6824 2001 106
8. M. Clerici, and G.M. Shearer A Th1 to Th2 switch is a critical step in the etiology of HIV infection Immunol. Today 14 1993 107
9. J.R. Currier, E.G. Kuta, E. Turk, L.B. Earhart, L. Loomis-Price, S. Janetzki, G. Ferrari, D.L. Birx, and J.H. Cox A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays J. Immunol. Methods 260 1-2 2002 157
10. R.T. Davey Jr., R.L. Murphy, F.M. Graziano, S.L. Boswell, A.T. Pavia, M. Cancio, J.P. Nadler, D.G. Chaitt, R.L. Dewar, and D.K. Sahner Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial JAMA 284 2 2000 183
11. S.C. De Rosa, F.X. Lu, J. Yu, S.P. Perfetto, J. Falloon, S. Moser, T.G. Evans, R. Koup, C.J. Miller, and M. Roederer Vaccination in humans generates broad T cell cytokine responses J. Immunol. 173 2004 5372
12. D.C. Douek, J.M. Brenchley, M.R. Betts, D.R. Ambrozak, B.J. Hill, Y. Okamoto, J.P. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, Z. Grossman, M. Dybul, A. Oxenius, D.A. Price, M. Connors, and R.A. Koup HIV preferentially infects HIV-specific CD4+ T cells Nature 417 6884 2002 95
13. R. Draenert, C.L. Verrill, Y. Tang, T.M. Allen, A.G. Wurcel, M. Boczanowski, A. Lechner, A.Y. Kim, T. Suscovich, N.V. Brown, M.M. Addo, and B.D. Walker Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection J. Virol. 78 2 2004 630
14. J.C. Gea-Banacloche, S.A. Migueles, L. Martino, W.L. Shupert, A.C. McNeil, M.S. Sabbaghian, L. Ehler, C. Prussin, R. Stevens, and L. Lambert Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-tern nonprogressors J. Immunol. 165 2000 1082
15. A. Harari, S.C. Zimmerli, and G.P. Pantaleo Cytomegalovirus (CMV)-specific cellular immune responses Hum. Immunol. 65 2004 500
16. A. Harari, F. Vallelian, P.R. Meylan, and G. Pantaleo Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence J. Immunol. 174 2 2005 1037
17. G.A. Hardy, N. Imami, A.K. Sullivan, A. Pires, C.T. Burton, M.R. Nelson, B.G. Gazzard, and F.M. Gotch Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness Clin. Exp. Immunol. 134 1 2003 98
18. G.A. Hardy, N. Imami, A.K. Sullivan, M.R. Nelson, B. Gazzard, and F.M. Gotch Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses. AIDS 18 16 2004 2199
19. T. Harrer, E. Harrer, S.A. Kalams, T. Elbeik, S.I. Staprans, M.B. Feinberg, Y. Cao, D.D. Ho, T. Yilma, A.M. Caliendo, R.P. Johnson, S.P. Buchbinder, and B.D. Walker Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type-1 infection AIDS Res. Hum. Retrovir. 12 7 1996 585
20. N. Imami, G.A. Hardy, M.R. Nelson, S. Morris-Jones, R. Al Shahi, C. Antonopoulos, B. Gazzard, and F.M. Gotch Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy Clin. Exp. Immunol. 118 1 1999 78
21. N. Imami, G. Hardy, C. Burton, A. Pires, J. Pido-Lopez, R. Moss, B. Gazzard, and F. Gotch Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination Immunol. Lett. 79 1-2 2001 63
22. N. Imami, A. Pires, G. Hardy, J. Wilson, B. Gazzard, and F. Gotch A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection J.Virol. 76 18 2002 9011
23. N.G. Jacobson, S.J. Szabo, R.M. Weber-Nordt, Z. Zhong, R.D. Schreiber, J.E. Darnell, and K.M. Murphy Interleukin 12 signaling in T helper type 1 (Th1) cells involves phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4 J. Exp. Med. 181 5 1995 1755
24. E.M. Janssen, E.E. Lemmens, T. Wolfe, U. Christen, M.G. von Herrath, and S.P. Schoenberger CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes Nature 421 6925 2003 852
25. A. Kebba, P. Kaleebu, S. Rowland, R. Ingram, J. Whitworth, N. Imami, and F. Gotch Distinct patterns of peripheral HIV-1-specific interferon-gamma responses in exposed HIV-1-seronegative individuals J. Infect. Dis. 189 9 2004 1705
26. A. Lalvani, R. Brookes, S. Hambleton, W.J. Britton, A.V. Hill, and A.J. McMichael Rapid effector function in CD8+ memory T cells J. Exp. Med. 186 6 1997 859
27. T.S. Li, R. Tubiana, C. Katlama, V. Calvez, M.H. Ait, and B. Autran Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease Lancet 351 9117 1998 1682
28. E. McLaughlin-Taylor, H. Pande, S. Forman, B. Tanamachi, C. Li, J. Zaia, P. Greenberg, and S. Riddell Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes J. Med. Virol. 43 1994 103
29. S.A. Migueles, A.C. Laborico, W.L. Shupert, M.S. Sabbaghian, R. Rabin, C.W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, L. Ehler, J. Metcalf, S. Liu, and M. Connors HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors Nat. Immunol. 3 11 2002 1061
30. P.J. Norris, and E.S. Rosenberg Cellular immune response to human immunodeficiency virus AIDS 15 Suppl. 2 2001 S16
31. G. Ogg, X. Jin, S. Bonhoeffer, P.R. Dunbar, M.A. Nowak, S. Monard, J.P. Segal, Y. Cao, S.L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D.D. Ho, D. Nixon, and A.J. McMichael Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA Science 279 1998 2103
32. F.J. Palella Jr., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, G.A. Satten, D.J. Aschman, and S.D. Holmberg Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N. Engl. J. Med. 338 13 1998 853
33. J. Pido-Lopez, C. Burton, G. Hardy, A. Pires, A. Sullivan, B. Gazzard, R. Aspinall, F. Gotch, and N. Imami Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune) AIDS Res. Hum. Retrovir. 19 2 2003 103
34. A. Rickinson, and D. Moss Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection Annu. Rev. Immunol. 15 1997 405
35. C.R. Rinaldo Jr., J.M. Liebmann, X.L. Huang, Z. Fan, Q. Al Shboul, D.K. McMahon, R.D. Day, S.A. Riddler, and J.W. Mellors Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens J. Infect. Dis. 179 2 1999 329
36. E.S. Rosenberg, J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams, and B.D. Walker Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia Science 278 5342 1997 1447
37. S.L. Rowland-Jones, T. Dong, L. Dorrell, G. Ogg, P. Hansasuta, P. Krausa, J. Kimani, S. Sabally, K. Ariyoshi, J. Oyugi, K.S. MacDonald, J. Bwayo, H. Whittle, F.A. Plummer, and A.J. McMichael Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors Immunol. Lett. 66 1-3 1999 9
38. M. Scholz, H.W. Doerr, and J. Cinatl Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence Trends Microbiol. 11 2003 171
39. D.J. Shedlock, and H. Shen Requirement for CD4 T cell help in generating functional CD8 T cell memory Science 300 5617 2003 337
40. M.D. Sheehy, A.B. McDermott, S.N. Furlan, P. Klenerman, and D.F. Nixon A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis J. Immunol. Methods 249 1-2 2001 99
41. A.K. Sullivan, G.A. Hardy, M.R. Nelson, F. Gotch, B.G. Gazzard, and N. Imami Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy AIDS 17 4 2003 628
42. J.C. Sun, and M.J. Bevan Defective CD8 T cell memory following acute infection without CD4 T cell help Science 300 5617 2003 339
43. A.W. Sylwester, B.L. Mitchell, J.B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P.R. Sleath, K.H. Grabstein, N.A. Hosken, F. Kern, J.A. Nelson, and L.J. Picker Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects J. Exp. Med. 202 5 2005 673
44. S.J. Szabo, N.G. Jacobson, A.S. Dighe, U. Gubler, and K.M. Murphy Developmental commitment to the Th2 lineage by extinction of IL-12 signaling Immunity 2 6 1995 665
45. S.J. Szabo, A.S. Dighe, U. Gubler, and K.M. Murphy Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells J. Exp. Med. 185 5 1997 817
46. M. Wills, A. Carmichael, K. Mynard, X. Jin, M. Weekes, B. Plachter, and J. Sissons The human cytotoxic T-lymphocytes (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL J. Virol. 70 1996 7569
47. J.D. Wilson, N. Imami, A. Watkins, J. Gill, P. Hay, B. Gazzard, M. Westby, and F.M. Gotch Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease J. Infect. Dis. 182 3 2000 792
48. S.A. Younes, B. Yassine-Diab, A.R. Dumont, M.R. Boulassel, Z. Grossman, J.P. Routy, and R.P. Sekaly HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity J. Exp. Med. 198 12 2003 1909